论文部分内容阅读
1987年,日本的富田勋研究组最早报导了茶叶中的主要组分-EGCG对人体癌细胞具有活体外的抑制作用以来,15年来发表了数以千计的研究报告。这些研究不仅来自中国、美国、和日本等国,目前已扩大到英国、意大利、瑞典、西班牙、以色列、加拿大、德国、荷兰、科威特、比利时等许多国家。我从网上查阅了从1999年末到2003年4月不足4年期间世界上发表的有关茶叶的论文,共有2900余篇。我惊奇地发现,有关茶与健康的论文竟有一千篇之多,占茶叶论文总数的三分之一,其中又以茶叶抗癌的内容为最多。这说明茶叶对人体健康的有益作用已越来越引起世界科学家的关注。
In 1987, Japan’s Tomita Research Group first published thousands of studies over the past 15 years since EGFG, the main component in tea, reported in vitro inhibition of human cancer cells. These studies have not only come from China, the United States, Japan and other countries, but have now expanded to many countries such as Britain, Italy, Sweden, Spain, Israel, Canada, Germany, the Netherlands, Kuwait and Belgium. I have reviewed online papers on tea published in the world from late 1999 to April 2003 in less than 4 years, with more than 2,900 papers. I was surprised to find that as many as a thousand papers on tea and health, accounting for one third of the total number of tea papers, of which tea is the most anti-cancer content. This shows that the beneficial effect of tea on human health has drawn more and more world scientists’ attention.